BioLoomics Competitors and Similar CompaniesClear all

BioLoomics's competitors and similar companies include 1X, UnitX, SRI International and LabGenius.

	BioLoomics BioLoomics is a preclinical-stage biotechnology company leveraging the directed evolution of antibodies in human cells to create target-degrading antibodies.	1X 1X Technologies (formerly known as Halodi Robotics) is a company that develops AI and robotics systems.	UnitX UnitX is a robotics company that provides AI for improved yield and quality.	SRI International SRI International (formerly Stanford Research Institute) is a nonprofit research and development institute.	LabGenius LabGenius is a company that provides machine learning (ML) driven antibody discovery solutions.
Founding Date	Founding Date 2019	Founding Date 2014	Founding Date 2018	Founding Date 1946	Founding Date 2012
Type	Type Private	Type Private	Type Private	Type Private	Type Private
Tags	Tags Technology artificial intelligence biotech robotics	Tags Technology artificial intelligence robotics	Tags Technology artificial intelligence robotics	Tags Education e-learning professional education	Tags Technology automation biotech machine learning platform robotics
Locations	Locations Boulder, US HQ	Locations Sunnyvale, US HQ Moss, NO Oslo, NO	Locations Santa Clara, US HQ	Locations Menlo Park, US HQ Tokyo, JP Aberdeen, US Ann Arbor, US Arlington, US Boulder, US Harrisonburg, US see more	Locations London, GB HQ London, GB
Employees	Employees 1616% decrease	Employees 5329% increase	Employees 931% increase	Employees 1,500	Employees 681% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) kr11.5m (FY, 2023)	Revenue (est.) N/A	Revenue (est.) $437.6m (FY, 2024)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods kr19.1m (FY, 2023)	Cost of goods N/A	Cost of goods $199m (FY, 2024)	Cost of goods £5.5m (FY, 2023)
Gross profit	Gross profit N/A	Gross profit (kr7.7m) (FY, 2023)	Gross profit N/A	Gross profit $238.5m (FY, 2024)	Gross profit (£5.5m) (FY, 2023)
Net income	Net income N/A	Net income (kr129.3m) (FY, 2023)	Net income N/A	Net income $2m (FY, 2024)	Net income (£6.8m) (FY, 2023)
Funding
Latest funding round	Latest funding round $ 8.7m (over 2 years ago)	Latest funding round $ 99.8m (over 2 years ago)	Latest funding round $ 5m (over 2 years ago)	Latest funding round $ 946.1k (over 16 years ago)	Latest funding round $ 15m (over 5 years ago)
Total funding raised	Total funding raised $ 19.5m	Total funding raised $ 99.8m	Total funding raised $ 5m	Total funding raised $ 1.4m	Total funding raised $ 28.7m